Dr. Nivedita Dhingra

Dr. Nivedita Dhingra

Hematology, Hemato-Oncology & Bone Marrow Transplant (Adult & Pediatrics)

Over 23 years

Yashoda Medicity, Indirapuram

Ghaziabad, India

Introduction

Dr. Nivedita Dhingra treats blood disorders and blood cancers in adults and children. People come to her for leukemia, lymphoma, myeloma, thalassemia, severe anemias, and cases needing bone marrow transplant or CAR-T cell therapy.

About Dr. Nivedita Dhingra

Dr. Nivedita Dhingra has been doing hematology for over twenty-one years now. Currently serves as Director & Head of Hematology, Hemato-Oncology, and Bone Marrow Transplant at Yashoda Medicity. She handles autologous, allogeneic, and haplo-identical bone marrow transplants. Also does CAR-T cell therapy for relapsed cases.

Dr. Nivedita got trained at MAMC, UCMS, Sir Ganga Ram Hospital, and AIIMS Delhi. Previously worked at Max Hospital, Jaypee Hospital, and AIIMS. He also won the Ravi K. Jerath Award and multiple gold medals for research.

Qualifications

  • MBBS from Maulana Azad Medical College (MAMC), New Delhi
  • MD (Paediatrics) from UCMS, New Delhi
  • FNB (Pediatric Hemato-Oncology) from Sir Ganga Ram Hospital, New Delhi
  • DM (Clinical Hematology) from AIIMS, New Delhi

Awards & Recognition

  • Ravi K. Jerath Award for Best FNB Trainee
  • Dr. V. Balagopal Raju Gold Medal at PEDICON (2009)
  • Shri Ram Vidyawanti Kakkar Memorial Gold Medal
  • Director & Head at Yashoda Medicity
  • Senior roles at Max, Jaypee, and AIIMS
  • Member of ISHBT, ISBMT, SIOP, ISPID

Specialities & Expertise

  • Leukemia & lymphoma
  • Multiple myeloma
  • Thalassemia & sickle cell
  • Bone marrow transplant
  • CAR-T cell therapy
  • Severe anemias
  • Primary immunodeficiencies
  • Pediatric hemato-oncology

Patient Experience & Approach

Patients say Dr. Dhingra explains transplant options without overwhelming families. When someone needs BMT or CAR-T, she walks through risks and recovery honestly. Parents of thalassemia kids appreciate that she discusses timing and donor options clearly.
Those who went through transplant mention that her team handled complications well and kept them informed throughout.